Used primarily in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting the central nervous system. Its structure supports the development of ligands for neurotransmitter receptors, including dopamine and serotonin receptors. Commonly employed in the creation of experimental agents for studying neurological disorders such as depression, anxiety, and addiction. Also utilized in the preparation of radiolabeled derivatives for positron emission tomography (PET) imaging due to the presence of fluorine, enabling non-invasive brain receptor mapping. Its amine functionality allows for easy derivatization, making it valuable in medicinal chemistry for structure-activity relationship studies.